Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia.

This publication has 25 references indexed in Scilit:

• Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
  The American Journal of Cardiology, 1998
• Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System fn1fn1This study was supported by a grant from the Kaneka America Corporation, New York, New York.
  The American Journal of Cardiology, 1998
• Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliterance
  Atherosclerosis, 1995
• Development of Immunosorbents for apoB-Containing Lipoproteins Apheresis
  Artificial Organs, 1995
• An Effective LDL Removal Filter for the Treatment of Hyperlipidemia
  Artificial Organs, 1995
• The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL‐cholesterol plasma concentrations and the course of coronary heart disease*
  European Journal of Clinical Investigation, 1994
• Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis
  The American Journal of Cardiology, 1994
• Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
  New England Journal of Medicine, 1984
• A NEW APPROACH TO THE MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLqMIA: REMOVAL OF PLASMA-CHOLESTEROL BASED ON THE PRINCIPLE OF AFFINITY CHROMATOGRAPHY
  The Lancet, 1976
• PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA
  The Lancet, 1975